Welcome to our dedicated page for Columbia Research Enhanced Core ETF news (Ticker: RECS), a resource for investors and traders seeking the latest updates and insights on Columbia Research Enhanced Core ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Columbia Research Enhanced Core ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Columbia Research Enhanced Core ETF's position in the market.
Columbia Threadneedle Investments celebrates the five-year anniversary of its Columbia Research Enhanced Core ETF (NYSE Arca: RECS), which has amassed over $1 billion in client assets. RECS has consistently outperformed its benchmark, the Russell 1000 Index®, through a unique rules-based approach that applies proprietary investment research.
The ETF's strategy addresses a key concern of financial advisors by eliminating unfavorably rated stocks from the benchmark. RECS has earned a 5-star Overall Morningstar Rating and ranks in the top 10% of Morningstar's U.S. Large Blend category for the five-year period ending September 30, 2024. With a total expense ratio of 0.15%, RECS offers a cost-effective and tax-efficient solution for core equity exposure.
Managed by Christopher Lo, Jason Wang, and Henry Hom, RECS uses Columbia Threadneedle's proprietary quantitative models to evaluate companies based on quality, value, and catalyst factors. As of September 30, 2024, the ETF contained 357 US large-cap stocks across growth and value sectors.
FAQ
What is the current stock price of Columbia Research Enhanced Core ETF (RECS)?
